Search results for "From ACP Internist"
SGLT2 inhibitors associated with rare, life-threatening necrotizing genital infections
In the past six years, nearly three times as many cases of Fournier gangrene were reported in patients taking sodium-glucose cotransporter-2 (SGLT2) inhibitors as in the past 35 years in patients taking other antiglycemic agents.
https://diabetes.acponline.org/archives/2019/05/10/11.htm
10 May 2019
Lower glucose levels before hospital discharge associated with readmission, death in diabetes patients
Even near-normal glucose levels on the last day of hospitalization were associated with increased risk for readmission and postdischarge mortality, and these risks increased as patients' glucose levels decreased.
https://diabetes.acponline.org/archives/2019/05/10/12.htm
10 May 2019
New guideline offers recommendations for older patients with diabetes or prediabetes
The Endocrine Society's new clinical practice guideline recommends lifestyle therapy, then metformin, then second-line drugs (but not sulfonylureas and glinides) or insulin for diabetes patients ages 65 years and older, among other advice.
https://diabetes.acponline.org/archives/2019/04/05/6.htm
5 Apr 2019
Canagliflozin may not increase fracture risk in patients at low risk for fractures
Although canagliflozin has been linked to decreased bone mineral density, patients with type 2 diabetes who initiated the drug had similar risk of a first fracture as those who started a glucagon-like peptide-1 receptor agonist.
https://diabetes.acponline.org/archives/2019/01/11/7.htm
11 Jan 2019
Expert panel recommends SGLT2 inhibitor or GLP-1 receptor agonist for patients with type 2 diabetes and CVD
The American College of Cardiology's new decision pathway also calls for repeated HbA1c screening and detailed clinician-patient risk discussions for patients with cardiovascular disease (CVD) who are diagnosed with type 2 diabetes.
https://diabetes.acponline.org/archives/2018/12/14/9.htm
14 Dec 2018
Diabetes outcomes similar when primary care provided by NPs, PAs, or physicians, study finds
More care by nurse practitioners (NPs) and physician assistants (PAs) may be a way to expand primary care access while maintaining quality standards.
https://diabetes.acponline.org/archives/2018/12/14/10.htm
14 Dec 2018
Newer, older insulin formulations may offer similar glucose-lowering effects
The findings may help inform decisions about insulin therapy for patients with type 2 diabetes, for example, when minimizing weight gain or nocturnal hypoglycemia is a priority.
https://diabetes.acponline.org/archives/2018/07/13/8.htm
13 Jul 2018
Reconciling conflicting diabetes guidance
ACP Internist discusses disagreement among professional medical societies on appropriate glycemic control goals following ACP's recent guidance recommending a higher target HbA1c.
https://diabetes.acponline.org/archives/2018/06/08/8.htm
8 Jun 2018
Diabetes remission through diet may be doable, with support
An article in the May ACP Internist discusses how intensive lifestyle interventions may be able to send type 2 diabetes into remission for selected patients.
https://diabetes.acponline.org/archives/2018/05/11/8.htm
11 May 2018
ACP recommends less intensive glucose control in most cases of type 2 diabetes
The evidence-based guidance statement from ACP calls for personalized goals and an HbA1c target between 7% and 8% for most patients with type 2 diabetes.
https://diabetes.acponline.org/archives/2018/03/09/6.htm
9 Mar 2018